| Name | Title | Contact Details |
|---|
CatalystRx is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Philadelphia, PA. To find more information about CatalystRx, please visit www.catalystrx.com
Founded in 2011, CareSync is the leading provider of software and services for chronic disease management, combining technology with 24/7 nursing services to facilitate care coordination among patients, family and caregivers and all providers. CareSync provides turnkey Chronic Care Management services as well as a software-only option, allowing practices of any size to easily meet the billing requirements for CPT code 99490. Additionally, CareSync`s certified technology makes it simple for providers to meet Meaningful Use 2 for Data Exchange, Messaging and Timely Access. CareSync patients are at the center of their healthcare, with access to health information, actionable goals, and Comprehensive Care Plan tasks. As a result, CareSync`s patients are experiencing more productive medical appointments and better health outcomes.
Vyne Medical serves a growing base of more than 800 active hospital and healthcare system clients nationwide. Best practices are hardwired through technology solutions proven to help hospitals achieve sustainable top performance. Our solutions create a unified view of patient health data, capturing information at the point of exchange and making it available at the point of need for faster response times, smoother transitions, improved patient experience, and better health outcomes.
SHI Consulting is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.